Age-related macular degeneration and nutritional supplementation:a review of randomised controlled trials

Article English OPEN
Bartlett, Hannah E. ; Eperjesi, Frank (2003)
  • Subject:
    mesheuropmc: eye diseases | genetic structures | sense organs

Age-related macular degeneration (AMD) is the leading cause of severe vision loss in the developed world. The lack of effective treatment modalities, coupled with evidence supporting an oxidative pathogenesis, has increased interest in the potential preventative role of nutritional supplementation. This article reviews seven randomised controlled trials (RCTs) that have investigated the role of nutritional supplementation in AMD. Three of these trials reported a positive effect of nutritional supplementation on AMD; the Age-related eye study (AREDS), the Lutein Antioxidant Supplementation Trial (LAST), and the oral zinc trial by Newsome et al. (1988). However, the oral zinc trial by Newsome et al. (1988) was unlikely to detect any difference between treatments smaller than 72%, and the AREDS results were based on a subgroup of their study population. Lutein was considered for the AREDS formulation, but was not commercially available at that time. The findings of the LAST support a possible therapeutic role of lutein in AMD. © 2004 The College of Optometrists.
  • References (140)
    140 references, page 1 of 14

    Abramson, D. and Abramson, H. (2002). High-Dose Supplements for AgeRelated Macular Degneration: Did You Leave Out Centrum? Archives of Ophthalmology. 120, 1602.

    Algvere, P. V. and Seregard, S. (2002). Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol. Scand. 80, 136-143.

    Alvarez, R., Liou, G. and Fong, S. (1987). Levels of alpha- and gammatocopherol in human eyes: evaluation of the possible role of IRBP in intraocular alpha-tocopherol transport. Am J Clin Nutr. 46, 481-487.

    Armstrong, R., Slade, S. and Eperjesi, F. (2000). An introduction to analysis variance (ANOVA) with special reference to data from clinical experiments in optometry. Ophthal. Physiol. Opt. 20, 235-241.

    Beardsley, T. (1991). The A Team. Vitamin A and its cousins are potent regulators of cells. Sci. Am. 16-19.

    Beatty, S., Boulton, M., Henson, D., Koh, H. H. and Murray, I. J. (1999). Macular pigment and age related macular degeneration. Br. J. Ophthalmol. 83, 867-877.

    Beatty, S., Koh, H., Carden, D. and Murray, I. (2000). Macular pigment optical density measurement: a novel compact instrument. Ophthal. Physiol. Opt. 20, 105-111.

    Beatty, S., Murray, I. J., Henson, D. B., Carden, D., Koh, H. and Boulton, M. E. (2001). Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest. Ophthalmol. Vis. Sci. 42, 439-446.

    Berendschot, T. T., Goldbohm, R. A., Klopping, W. A., van de Kraats, J., van Norel, J. and van Norren, D. (2000). Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Investigative Ophthalmology & Visual Science. 41, 3322-3326.

    Berger, A. (2002). Science commentary: What does zinc do? Br. Med. J. 325, 1063-1063.

  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Aston Publications Explorer - IRUS-UK 0 78
Share - Bookmark